Rotavirus Infection Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: REEFA064D514EN
Market Monitor Global

Abstracts

Rotavirus (RV) is a double-stranded ribonucleic acid virus, which belongs to the reovirus family. It is the single leading cause of diarrhea in infants and young children, and almost every child in the world around the age of five has been infected with rotavirus at least once.

This report contains market size and forecasts of Rotavirus Infection Therapeutics in Global, including the following market information:

Global Rotavirus Infection Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Rotavirus Infection Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rotavirus Infection Therapeutics include GlaxoSmithKline, Bharat Biotech, Curevac, Ology Bioservices and BioKangtai, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rotavirus Infection Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rotavirus Infection Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Rotavirus Infection Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Oral Drug
• Injiectable Drug

Global Rotavirus Infection Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Rotavirus Infection Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Rotavirus Infection Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Rotavirus Infection Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rotavirus Infection Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Rotavirus Infection Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• Bharat Biotech
• Curevac
• Ology Bioservices
• BioKangtai

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Rotavirus Infection Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Rotavirus Infection Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ROTAVIRUS INFECTION THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Rotavirus Infection Therapeutics Market Size: 2021 VS 2028
2.2 Global Rotavirus Infection Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Rotavirus Infection Therapeutics Players in Global Market
3.2 Top Global Rotavirus Infection Therapeutics Companies Ranked by Revenue
3.3 Global Rotavirus Infection Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Rotavirus Infection Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rotavirus Infection Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rotavirus Infection Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Rotavirus Infection Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Rotavirus Infection Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Rotavirus Infection Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Oral Drug
  4.1.3 Injiectable Drug
4.2 By Type - Global Rotavirus Infection Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Rotavirus Infection Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Rotavirus Infection Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Rotavirus Infection Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Rotavirus Infection Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Rotavirus Infection Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Rotavirus Infection Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Rotavirus Infection Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Rotavirus Infection Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Rotavirus Infection Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Rotavirus Infection Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Rotavirus Infection Therapeutics Revenue, 2017-2028
  6.3.2 US Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.3.3 Canada Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Rotavirus Infection Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Rotavirus Infection Therapeutics Revenue, 2017-2028
  6.4.2 Germany Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.4.3 France Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.4.5 Italy Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.4.6 Russia Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Rotavirus Infection Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Rotavirus Infection Therapeutics Revenue, 2017-2028
  6.5.2 China Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.5.3 Japan Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.5.6 India Rotavirus Infection Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Rotavirus Infection Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Rotavirus Infection Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.7.3 Israel Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Rotavirus Infection Therapeutics Market Size, 2017-2028
  6.7.5 UAE Rotavirus Infection Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Rotavirus Infection Therapeutics Major Product Offerings
  7.1.4 GlaxoSmithKline Rotavirus Infection Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 Bharat Biotech
  7.2.1 Bharat Biotech Corporate Summary
  7.2.2 Bharat Biotech Business Overview
  7.2.3 Bharat Biotech Rotavirus Infection Therapeutics Major Product Offerings
  7.2.4 Bharat Biotech Rotavirus Infection Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Bharat Biotech Key News
7.3 Curevac
  7.3.1 Curevac Corporate Summary
  7.3.2 Curevac Business Overview
  7.3.3 Curevac Rotavirus Infection Therapeutics Major Product Offerings
  7.3.4 Curevac Rotavirus Infection Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Curevac Key News
7.4 Ology Bioservices
  7.4.1 Ology Bioservices Corporate Summary
  7.4.2 Ology Bioservices Business Overview
  7.4.3 Ology Bioservices Rotavirus Infection Therapeutics Major Product Offerings
  7.4.4 Ology Bioservices Rotavirus Infection Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Ology Bioservices Key News
7.5 BioKangtai
  7.5.1 BioKangtai Corporate Summary
  7.5.2 BioKangtai Business Overview
  7.5.3 BioKangtai Rotavirus Infection Therapeutics Major Product Offerings
  7.5.4 BioKangtai Rotavirus Infection Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 BioKangtai Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Rotavirus Infection Therapeutics Market Opportunities & Trends in Global Market
Table 2. Rotavirus Infection Therapeutics Market Drivers in Global Market
Table 3. Rotavirus Infection Therapeutics Market Restraints in Global Market
Table 4. Key Players of Rotavirus Infection Therapeutics in Global Market
Table 5. Top Rotavirus Infection Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rotavirus Infection Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rotavirus Infection Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rotavirus Infection Therapeutics Product Type
Table 9. List of Global Tier 1 Rotavirus Infection Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rotavirus Infection Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rotavirus Infection Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rotavirus Infection Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Rotavirus Infection Therapeutics Product Offerings
Table 32. GlaxoSmithKline Rotavirus Infection Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Bharat Biotech Corporate Summary
Table 34. Bharat Biotech Rotavirus Infection Therapeutics Product Offerings
Table 35. Bharat Biotech Rotavirus Infection Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Curevac Corporate Summary
Table 37. Curevac Rotavirus Infection Therapeutics Product Offerings
Table 38. Curevac Rotavirus Infection Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Ology Bioservices Corporate Summary
Table 40. Ology Bioservices Rotavirus Infection Therapeutics Product Offerings
Table 41. Ology Bioservices Rotavirus Infection Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. BioKangtai Corporate Summary
Table 43. BioKangtai Rotavirus Infection Therapeutics Product Offerings
Table 44. BioKangtai Rotavirus Infection Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Rotavirus Infection Therapeutics Segment by Type in 2021
Figure 2. Rotavirus Infection Therapeutics Segment by Application in 2021
Figure 3. Global Rotavirus Infection Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rotavirus Infection Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rotavirus Infection Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rotavirus Infection Therapeutics Revenue in 2021
Figure 8. By Type - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bharat Biotech Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Curevac Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Ology Bioservices Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BioKangtai Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)